Xenon Pharmaceuticals (XENE) Deferred Taxes (2018 - 2026)
Xenon Pharmaceuticals' (XENE) quarterly Deferred Taxes came in at $447000.0 in Q1 2026, up 136.85% year-on-year from $188726.4 in Q1 2025, and up 140.13% on a QoQ basis from -$1.1 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Deferred Taxes (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 9 years of Deferred Taxes data on file, last reported at $447000.0 in Q1 2026.
- On a quarterly basis, Deferred Taxes rose 136.85% year-over-year to $447000.0 in Q1 2026; TTM through Mar 2026 was -$1.5 million, a 85.32% increase from a year earlier, with the FY2025 full-year figure at -$3.2 million, up 63.92% from the prior year.
- Deferred Taxes for Q1 2026 stood at $447000.0, up from -$1.1 million in the prior quarter.
- Over the last five years, Deferred Taxes for XENE reached as high as $447000.0 in Q1 2026 and fell as low as -$8.6 million in Q4 2024.
- Historically, Deferred Taxes has averaged -$703000.0 across 5 years, with a median of -$200000.0 in 2023.
- Across the five-year window, Deferred Taxes jumped 2766.67% in 2022 and slumped 4206.0% in 2024, its largest moves.
- Year by year, Deferred Taxes stood at $5000.0 in 2022, then tumbled by 4100.0% to -$200000.0 in 2023, then slumped by 4206.0% to -$8.6 million in 2024, then soared by 87.06% to -$1.1 million in 2025, then surged by 140.13% to $447000.0 in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were $447000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$701000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | 447,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -170,000.00 |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -8.61 Mn |
| Sep 30, 2024 | -322,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -156,000.00 |
| Jun 30, 2023 | -224,000.00 |
| Mar 31, 2023 | 288,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | -203,000.00 |
| Jun 30, 2022 | -104,000.00 |
| Mar 31, 2022 | 258,000.00 |
| Dec 31, 2021 | 346,000.00 |
| Sep 30, 2021 | -267,000.00 |
| Jun 30, 2021 | -30,000.00 |